XBiotech (XBIT) Profit After Tax (2014 - 2026)

XBiotech has reported Profit After Tax for 13 years, with the latest figure at -$6.7 million in Q2 2026.

• On a quarterly basis, Profit After Tax fell 283.14% year-over-year to -$6.7 million in Q2 2026; TTM through Jun 2026 was -$41.4 million, a 46.94% decrease from a year earlier, with the FY2025 full-year figure at -$45.5 million, down 18.19% from the prior year.
• Profit After Tax was -$6.7 million for Q2 2026 at XBiotech, up from -$26.9 million in the prior quarter.
• The five-year high for Profit After Tax was -$1.8 million in Q2 2025, with the low at -$26.9 million in Q4 2025.
• Average Profit After Tax over 5 years is -$8.7 million, with a median of -$7.4 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Profit After Tax slumped 288.16% in 2022, then jumped 86.5% in 2025.
• Over 5 years, Profit After Tax stood at -$3.2 million in 2022, then tumbled by 44.71% to -$4.6 million in 2023, then slumped by 126.71% to -$10.5 million in 2024, then tumbled by 155.92% to -$26.9 million in 2025, then jumped by 74.98% to -$6.7 million in 2026.
• The last three Profit After Tax figures came in at -$6.7 million (Q2 2026), -$26.9 million (Q4 2025), and -$6.0 million (Q3 2025), per Business Quant data.